Kiniksa Pharmaceuticals: 3 Key Takeaways for Long-Term Investors
Profit growth is outpacing revenue gains, giving the company firepower to advance pipeline candidates without diluting shareholders.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.